Stock News

aTyr Pharma to Present Poster at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
aTyr Pharma Announces Publication of Two Abstracts in American Journal of Respiratory and Critical Care Medicine
aTyr Pharma Announces Phase 2 Study of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications Following FDA Acceptance of IND Application
aTyr Pharma, Inc. to Host Earnings Call
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Announce Government Grant to Fund Bispecific Antibody Development Platform
Leading Cancer Researcher Dr. Arthur M. Mercurio Joins aTyr as Scientific Advisor
aTyr Pharma Announces Exercise and Closing of Over-Allotment Option in Public Offering
aTyr Pharma Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting
aTyr Pharma Announces Publication in the Journal Cellular and Molecular Immunology
aTyr Pharma Announces Pricing of $18 million Underwritten Public Offering

As seen on...